Contact Us 888-901-2226
Donate Now

Bladder Cancer Treatment Guidelines

Clinical practice guidelines (or simply “guidelines”) are recommendations on how to diagnose and treat disease, like bladder cancer. They are mainly written for doctors, but also for nurses and other health care professionals. Guidelines are developed by experts after reviewing the research that improves the quality, effectiveness, and efficiency of cancer care.

Guidelines summarize current medical knowledge. Experts weigh the benefits and harms of diagnostic procedures and treatments. They give specific recommendations based on this information. They also provide information about the scientific evidence supporting those recommendations. Clinical guidelines are meant to help ensure that patients receive appropriate treatment and care.

Experts from the American Urological Association (AUA), the Society of Urologic Oncology (SUO), the American Society for Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the Society for Immunotherapy of Cancer (SITC), and the National Comprehensive Cancer Network® (NCCN®) have developed guidelines for bladder cancer. Ask your doctor to follow those guidelines.

Access those guidelines here:

Microhematuria: AUA/SUFU Guidelines (2020)

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Joint Guideline (2020)

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline (2017)

NCCN Bladder Cancer Guidelines. 

NCCN Bladder Cancer Guidelines – for patients.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.

NCCN Guidelines for Supportive Care(Includes managing pain, nausea, fatigue, and palliative care.)

Walk with BCAN, Talk with BCAN

Please join us for two exciting virtual events
in October 2020

Fall Virtual Walk to End Bladder Cancer
October 3, 2020 at 11:00 am ET

Virtual Summit for Patients and Families
October 10, 2020 at 1:00 pm ET